ICYMI: Yesterday, the U.S. Food and Drug Administration (FDA) to approve teplizumab (under the brand name Tzield) for use in delaying type 1 diabetes (T1D) in at-risk individuals. This HUGE news for the #T1D community! Learn more by swiping through the carousel, and at the link in our bio!